• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

研究各种阈值作为免疫组织化学观察者一致性的临界值。

Investigating Various Thresholds as Immunohistochemistry Cutoffs for Observer Agreement.

作者信息

Ali Asif, Bell Sarah, Bilsland Alan, Slavin Jill, Lynch Victoria, Elgoweini Maha, Derakhshan Mohammad H, Jamieson Nigel B, Chang David, Brown Victoria, Denley Simon, Orange Clare, McKay Colin, Carter Ross, Oien Karin A, Duthie Fraser R

机构信息

*Institute of Cancer Sciences, College of Medical, Veterinary and Life Sciences, University of Glasgow §Institute of Cardiovascular and Medical Sciences, University of Glasgow, Western Infirmary ¶Academic Unit of Surgery, School of Medicine, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow Royal Infirmary ‡Department of Pathology, Laboratory Medicine Building, Queen Elizabeth University Hospital, Greater Glasgow & Clyde NHS ∥West of Scotland Pancreatic Unit and Glasgow Royal Infirmary, Alexandra Parade, Glasgow #Pathology Laboratory, Forth Valley Royal Hospital, Larbert, UK †Institute of Basic Medical Sciences, Khyber Medical University, Peshawar, Pakistan.

出版信息

Appl Immunohistochem Mol Morphol. 2017 Oct;25(9):599-608. doi: 10.1097/PAI.0000000000000357.

DOI:10.1097/PAI.0000000000000357
PMID:27093449
Abstract

BACKGROUND

Clinical translation of immunohistochemistry (IHC) biomarkers requires reliable and reproducible cutoffs or thresholds for interpretation of immunostaining. Most IHC biomarker research focuses on the clinical relevance (diagnostic, prognostic, or predictive utility) of cutoffs, with less emphasis on observer agreement using these cutoffs. From the literature, we identified 3 commonly used cutoffs of 10% positive epithelial cells, 20% positive epithelial cells, and moderate to strong staining intensity (+2/+3 hereafter) to use for investigating observer agreement.

MATERIALS AND METHODS

A series of 36 images of microarray cores stained for 4 different IHC biomarkers, with variable staining intensity and percentage of positive cells, was used for investigating interobserver and intraobserver agreement. Seven pathologists scored the immunostaining in each image using the 3 cutoffs for positive and negative staining. Kappa (κ) statistic was used to assess the strength of agreement for each cutoff.

RESULTS

The interobserver agreement between all 7 pathologists using the 3 cutoffs was reasonably good, with mean κ scores of 0.64, 0.59, and 0.62, respectively, for 10%, 20%, and +2/+3 cutoffs. A good agreement was observed for experienced pathologists using the 10% cutoff, and their agreement was statistically higher than for junior pathologists (P=0.02). In addition, the mean intraobserver agreement for all 7 pathologists using the 3 cutoffs was reasonably good, with mean κ scores of 0.71, 0.60, and 0.73, respectively, for 10%, 20%, and +2/+3 cutoffs. For all 3 cutoffs, a positive correlation was observed with perceived ease of interpretation (P<0.003). Finally, cytoplasmic-only staining achieved higher agreement using all 3 cutoffs than mixed staining patterns.

CONCLUSIONS

All 3 cutoffs investigated achieve reasonable strength of agreement, modestly decreasing interobserver and intraobserver variability in IHC interpretation. These cutoffs have previously been used in cancer pathology, and this study provides evidence that these cutoffs can be reproducible between practicing pathologists.

摘要

背景

免疫组化(IHC)生物标志物的临床转化需要可靠且可重复的临界值或阈值来解释免疫染色结果。大多数IHC生物标志物研究聚焦于临界值的临床相关性(诊断、预后或预测效用),而较少强调使用这些临界值时观察者之间的一致性。从文献中,我们确定了3个常用的临界值,即10%阳性上皮细胞、20%阳性上皮细胞以及中等至强染色强度(以下简称+2/+3),用于研究观察者之间的一致性。

材料与方法

一系列36张微阵列芯块的图像,针对4种不同的IHC生物标志物进行染色,染色强度和阳性细胞百分比各不相同,用于研究观察者间和观察者内的一致性。7名病理学家使用阳性和阴性染色的3个临界值对每张图像的免疫染色进行评分。kappa(κ)统计量用于评估每个临界值的一致性强度。

结果

所有7名病理学家使用这3个临界值时观察者间的一致性相当好,对于10%、20%和+2/+3临界值,平均κ评分分别为0.64、0.59和0.62。经验丰富的病理学家使用10%临界值时观察到良好的一致性,且他们的一致性在统计学上高于初级病理学家(P = 0.02)。此外,所有7名病理学家使用这3个临界值时观察者内的平均一致性相当好,对于10%、20%和+2/+3临界值,平均κ评分分别为0.71、0.60和0.73。对于所有3个临界值,观察到与感知的解释难易程度呈正相关(P < 0.003)。最后,仅细胞质染色在使用所有3个临界值时比混合染色模式达成更高的一致性。

结论

所研究的所有3个临界值均达成了合理的一致性强度,在一定程度上降低了IHC解释中观察者间和观察者内的变异性。这些临界值此前已用于癌症病理学,本研究提供了证据表明这些临界值在执业病理学家之间具有可重复性。

相似文献

1
Investigating Various Thresholds as Immunohistochemistry Cutoffs for Observer Agreement.研究各种阈值作为免疫组织化学观察者一致性的临界值。
Appl Immunohistochem Mol Morphol. 2017 Oct;25(9):599-608. doi: 10.1097/PAI.0000000000000357.
2
Validity and Reproducibility of Immunohistochemical Scoring by Trained Non-Pathologists on Tissue Microarrays.非病理学家在组织微阵列上进行免疫组织化学评分的有效性和可重复性。
Cancer Epidemiol Biomarkers Prev. 2021 Oct;30(10):1867-1874. doi: 10.1158/1055-9965.EPI-21-0295. Epub 2021 Jul 16.
3
High interobserver and intraobserver reproducibility among pathologists assessing PD-L1 CPS across multiple indications.病理学家在评估多个适应证的 PD-L1 CPS 时具有较高的观察者间和观察者内可重复性。
Histopathology. 2022 Dec;81(6):732-741. doi: 10.1111/his.14775. Epub 2022 Sep 23.
4
Interobserver reproducibility of cervical histology interpretation with and without p16 immunohistochemistry.宫颈组织学解读中 p16 免疫组化的应用与不应用的观察者间重复性。
Am J Clin Pathol. 2024 Aug 1;162(2):202-209. doi: 10.1093/ajcp/aqae029.
5
Interobserver agreement in programmed cell death-ligand 1 immunohistochemistry scoring in nonsmall cell lung carcinoma cytologic specimens.程序性细胞死亡配体 1 免疫组织化学评分在非小细胞肺癌细胞学标本中的观察者间一致性。
Diagn Cytopathol. 2021 Feb;49(2):219-225. doi: 10.1002/dc.24651. Epub 2020 Oct 26.
6
Intra- and interobserver reproducibility of interpretation of immunohistochemical stains of prostate cancer.前列腺癌免疫组化染色判读的观察者内和观察者间可重复性。
Virchows Arch. 2009 Oct;455(4):375-81. doi: 10.1007/s00428-009-0833-8. Epub 2009 Sep 18.
7
The impact of a pathologist's personality on the interobserver variability and diagnostic accuracy of predictive PD-L1 immunohistochemistry in lung cancer.病理学家的个性对肺癌中预测性PD-L1免疫组化的观察者间变异性和诊断准确性的影响。
Lung Cancer. 2022 Apr;166:143-149. doi: 10.1016/j.lungcan.2022.03.002. Epub 2022 Mar 5.
8
p16 immunohistochemistry in oropharyngeal squamous cell carcinoma: a comparison of antibody clones using patient outcomes and high-risk human papillomavirus RNA status.p16 免疫组化在口咽鳞状细胞癌中的应用:基于患者结局和高危型人乳头瘤病毒 RNA 状态比较抗体克隆。
Mod Pathol. 2017 Sep;30(9):1194-1203. doi: 10.1038/modpathol.2017.31. Epub 2017 Jun 16.
9
Accuracy of human epidermal growth factor receptor 2 (HER2) immunohistochemistry scoring by pathologists in breast cancer, including the HER2-low cutoff : HER2 IHC scoring concordance in breast cancer.病理学家对乳腺癌中人表皮生长因子受体2(HER2)免疫组化评分的准确性,包括HER2低表达临界值:乳腺癌中HER2免疫组化评分的一致性
Diagn Pathol. 2025 Apr 4;20(1):35. doi: 10.1186/s13000-025-01624-3.
10
Application of LEF-1 immunohistochemical staining in the diagnosis of solid pseudopapillary neoplasm of the pancreas.LEF-1 免疫组织化学染色在胰腺实性假乳头状瘤诊断中的应用。
Pathol Res Pract. 2024 Nov;263:155662. doi: 10.1016/j.prp.2024.155662. Epub 2024 Oct 16.

引用本文的文献

1
Preliminary insights on the mutational spectrum of BRCA1 and BRCA2 genes in Pakhtun ethnicity breast cancer patients from Khyber Pakhtunkhwa (KP), Pakistan.巴基斯坦开伯尔-普赫图赫瓦省(KP)帕克蒂亚族群乳腺癌患者中 BRCA1 和 BRCA2 基因的突变谱的初步见解。
Neoplasia. 2024 May;51:100989. doi: 10.1016/j.neo.2024.100989. Epub 2024 Mar 27.
2
A Simple Panel of IDH1 and P53 in Differential Diagnosis Between Low-Grade Astrocytoma and Reactive Gliosis.用于低级别星形细胞瘤与反应性胶质增生鉴别诊断的IDH1和P53简易检测组合
Clin Pathol. 2021 Feb 11;14:2632010X20986168. doi: 10.1177/2632010X20986168. eCollection 2021 Jan-Dec.
3
Involvement of the TNF-α Pathway in TKI Resistance and Suggestion of TNFR1 as a Predictive Biomarker for TKI Responsiveness in Clear Cell Renal Cell Carcinoma.
肿瘤坏死因子-α通路在 TKI 耐药中的作用及 TNFR1 作为透明细胞肾细胞癌 TKI 反应性预测生物标志物的建议。
J Korean Med Sci. 2020 Feb 10;35(5):e31. doi: 10.3346/jkms.2020.35.e31.